APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
Exploring AI-Powered ATTR-CM Detection
Anticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights
Charles Turck, PharmD, BCPS, BCCCP
Akshay Kumar, MD
New Universal Definition Reframes Heart Failure Beyond Ejection Fraction
Ryan Quigley
ACACIA-HCM: What Do the Phase 3 Results Show?
Ahmad Masri, MD, MS
A Systematic Framework for Pediatric Acute Decompensated Heart Failure
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Carolyn Lam, MD, PhD
Stephen J. Greene, MD
Managing Acute PE: Updates from the 2026 AHA/ACC Guideline
Mary Leuchars, MD
Mark Creager, MD
How PCSK9 Inhibition Lowers LDL Cholesterol
Ann Marie Navar, MD, PhD
From Goals to Action: Multisociety Guidance on Lipid Management
Moving Toward Precision Medicine in PAH
Stephen Y. Chan, MD, PhD, FAHA
What’s Next for Pulmonary Arterial Hypertension Care?
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.